CH-5164840 is a novel, highly potent and selective HSP90 inhibitor with antitumor activity against NSCLC cell lines and xenograft models. CH5164840 has potent antitumor activity and is highly effective in combination with erlotinib against NSCLC tumors with EGFR overexpression and mutations.

纯度：≥98%

CAS：1052645-73-4